Markets
BSE See NSE See 33,359.90
17.10 (0.05%)
collapse Related Readings collapse

No summer surprise offer for Jio users

By Sanket Dewarkar | 4/7/2017 12:08 PM Friday

The Telecom Regulatory Authority of India (TRAI) on Thursday asked Jio to withdraw the three months complimentary offer of 'JIO Summer Surprise.'

On March 31, JIO had announced its summer surprise offer. Under this offer, all JIO prime members making their first recharge with Rs 303 or higher plans got three months complimentary services in addition to the benefits of their purchased plan.

JIO has decided to fully obey the regulator’s advice and will be withdrawing the three months complimentary benefits of Jio Summer Surprise as soon as operationally feasible, over the next few days.

However the company announced, “those who have already subscribed for the JIO summer surprise offer will remain eligible for the offer.”

The impact of withdrawal of this offer was visible in Friday’s trade as the shares of Bharti Airtel and Idea Cellular hiked by 2 per cent and 3 per cent respectively, where Bharti Airtel made an intraday high of Rs 349.65 and Idea Cellular shares touched a high of Rs 89.30.

 

Find More Articles on: Markets, DSIJ Mindshare

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

Mangalam Drugs posts 31 per cent growth in profit, stock surges

Mangalam Drugs posts 31 per cent growth in profit, stock surges

Pharma company Mangalam Drugs & Organics' stock rallied on Monday as the company announced its second quarter results for the financial year 2018.

Private banks spike up

Private banks spike up

In an otherwise lacklustre trading session, private banks rallied on Monday. Yes Bank, IndusInd Bank and Kotak Bank were trading higher.

 

Biocon surges 6 per cent on EIR from USFDA

Biocon surges 6 per cent on EIR from USFDA

Pharma company Biocon shot up by over 6 per cent in early trade on Monday as the company received the EIR from the USFDA.

GST illuminates logistic earnings

GST illuminates logistic earnings

The sector is reaping benefits of GST regime now, as we can observe from the earnings. GST implementation has changed the industry aspects and tax structure which aided the overall growth of the companies.

Strides Shasun and Eris Lifesciences surge post acquisition deal

Strides Shasun and Eris Lifesciences surge post acquisition deal

The Indian brand business of Strides Shasun is acquired by Eris Lifesciences for a cash consideration of Rs 500 crore. The company informed the stock exchanges through a filing on Monday.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.25 p.m. on November 20.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on November 20 opened up. BSE Sensex is trading at 33,349.14, up by 6.34 points and the Nifty is trading at 10,283.20, down by 0.40 points.

Glenmark Pharma up by 2 per cent on USFDA nod for Hailey 24

Glenmark Pharma up by 2  per cent  on USFDA nod for Hailey 24

Pharma major, Glenmark Pharmaceuticals received the final nod of USFDA for Hailey 24 Fe. The stock of the company surged by over 2 per cent in the intraday trade on Monday.

Cipla gets final approval for generic Dacogen

Cipla gets final approval for generic Dacogen

Pharma major, Cipla has announced that it has received final ANDA approval for decitabine injection 50 mg vial from the USFDA.

 

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.03 lakh contracts with a turnover of Rs. 5,33,783.20 crore.